Glucose News and Research

RSS

Sleep duration negatively impacts on self-rated health

Individuals who experience long or short sleep durations are more likely to report poor self-rated health than healthy sleepers, Korean study findings suggest.

14 Oct 2013

Island Doctors to host community diabetes awareness campaigns across NE Florida

On October 12th and 13th, Island Doctors will participate, sponsor, and co-host three events in Putnam and St. Johns County, Florida. The events are part of Island Doctors continued commitment to community diabetes awareness campaigns across NE Florida.

12 Oct 2013

New research shows blood pressure remains major problem in China

With a recent World Health Organization (WHO) report1 showing hypertension affects over 40% of Chinese adults aged 45 or older, combating high blood pressure (BP) will be high on the agenda of the 24th Great Wall International Congress of Cardiology & Asia Pacific Heart Congress (GW-ICC & APHC), in Beijing (10 to 13 October 2013).

11 Oct 2013

New less invasive surgical method paves way for development of efficient anti-obesity therapies

Bariatric surgeries, such as a gastric bypass, are currently the most effective anti-obesity therapies. They also lead to a reduced insulin resistance. However, the pitfall of these surgical interventions is that they are highly invasive and often permanent procedures.

11 Oct 2013

Hypertension affects over 40% of Chinese adults, shows WHO report

With a recent World Health Organization report showing hypertension affects over 40% of Chinese adults aged 45 or older, combating high blood pressure will be high on the agenda of the 24th Great Wall International Congress of Cardiology & Asia Pacific Heart Congress, in Beijing (10 to 13 October 2013).

10 Oct 2013

Compugen drug candidate prevents autoimmune type I diabetes in animal model

Compugen Ltd., announced today that CGEN-15001, an Fc fusion protein drug candidate derived from a novel immune checkpoint protein discovered by Compugen, has been shown to be highly efficient in preventing the development of disease in a well-accepted animal model of autoimmune type I diabetes, known also as juvenile diabetes.

9 Oct 2013

Salk scientist receives Career Development Award for new research from JDRF

The Juvenile Diabetes Research Foundation has given Salk scientist Mark Huising a five-year, $750,000 Career Development Award for his proposed study on how a novel network of receptors in human islets receives and integrates molecular signals. In pre-clinical models, activation of these receptors has proven to actually prevent diabetes.

9 Oct 2013

Hyperglycemia heightens pneumonia risk in pediatric burns patients

Research indicates that hyperglycemia puts pediatric burns patients at increased risk for pneumonia.

8 Oct 2013

Diabetic retinopathy incidence in upward trend

Retinal damage is one of the most common complications of diabetes, affecting about 90 percent of type 1 diabetics and 75 percent of type 2 diabetics. According to the World Health Organization (WHO), diabetic retinopathy is the leading cause of blindness in adults of working age, and its incidence is showing an upward trend.

8 Oct 2013

Nutranomics releases results of human patient clinical studies regarding Glucozyme

Nutranomics, Inc. (OTCBB: NNRX) (OTCQB: NNRX) ("Nutranomics" or the "Company") is pleased to announce that the results of human patient clinical studies undertaken by the Company regarding Glucozyme™ are nearing a public release date.

5 Oct 2013

Digital security: an interview with Jon Edgcombe, leader of the software technologies group at Cambridge Consultants

Digital security is a key requirement in our product designs, especially in markets such as healthcare where the design is complete long before final regulatory approval. From a commercial point of view, ignoring data privacy, device authentication, and anti-counterfeit at design stage is no longer a tenable position for a connected product that produces sensitive patient data – even if it is nominally pseudonomised.

2 Oct 2013

High blood glucose levels associated with higher risk of wound-related complications

A new study released today shows that among patients undergoing surgery for chronic wounds related to diabetes, the risk of wound-related complications is affected by how well the patient's blood sugar levels are controlled before surgery. These findings appear in the October issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

2 Oct 2013

Discovery paves way for new therapeutic strategies to protect heart health of diabetes patients

UC Davis Health System researchers have identified for the first time a biological pathway that is activated when blood sugar levels are abnormally high and causes irregular heartbeats, a condition known as cardiac arrhythmia that is linked with heart failure and sudden cardiac death.

1 Oct 2013

Insulin interaction map could lead to new therapeutic targets for type 2 diabetes

A team led by scientists at The Scripps Research Institute has created the first comprehensive roadmap of the protein interactions that enable cells in the pancreas to produce, store and secrete the hormone insulin. The finding makes possible a deeper scientific understanding of the insulin secretion process—and how it fails in insulin disorders such as type 2 diabetes.

1 Oct 2013

Roadmap of protein interactions may lead to new therapeutic approaches for type 2 diabetes

A team led by scientists at The Scripps Research Institute (TSRI) has created the first comprehensive roadmap of the protein interactions that enable cells in the pancreas to produce, store and secrete the hormone insulin.

1 Oct 2013

Diabetes puts you at increased risk of flu-related complications

There are certain groups of people who are at risk of serious flu complications each year, including those with diabetes.

30 Sep 2013

Study provides new insights into type 1 diabetes pathology

Joslin researchers have identified immune cells that promote growth of beta cells in type 1 diabetes. This study provides further evidence of a changed role for immune cells in type 1 diabetes pathology. The study appears online today and will also appear in the January issue of Diabetes.

29 Sep 2013

JDRF applauds FDA approval of Medtronic's MiniMed 530G with Enlite system for T1D

JDRF, the leading global organization funding type 1 diabetes research, today applauded the U.S. Food and Drug Administration for its commitment to ensuring patients in the United States can access insulin pumps that can temporarily stop insulin delivery once sensor glucose levels fall below a predetermined threshold.

From Medtronic 29 Sep 2013

Dextrose gel could treat neonatal hypoglycemia

A cheap and easy-to-administer dextrose gel should be used to treat low blood sugars in newborns (neonatal hypoglycaemia), a common problem that affects up to 15% of otherwise healthy babies, and a preventable cause of brain damage, according to new research published in The Lancet.

27 Sep 2013

Research on bone-derived hormone could lead to new treatments for memory loss, depression

Researchers from Columbia University Medical Center (CUMC) have found that the skeleton, acting through the bone-derived hormone osteocalcin, exerts a powerful influence on prenatal brain development and cognitive functions such as learning, memory, anxiety, and depression in adult mice.

27 Sep 2013

Glucose News and Research

Sleep duration negatively impacts on self-rated health

Island Doctors to host community diabetes awareness campaigns across NE Florida

New research shows blood pressure remains major problem in China

New less invasive surgical method paves way for development of efficient anti-obesity therapies

Hypertension affects over 40% of Chinese adults, shows WHO report

Compugen drug candidate prevents autoimmune type I diabetes in animal model

Salk scientist receives Career Development Award for new research from JDRF

Hyperglycemia heightens pneumonia risk in pediatric burns patients

Diabetic retinopathy incidence in upward trend

Nutranomics releases results of human patient clinical studies regarding Glucozyme

Digital security: an interview with Jon Edgcombe, leader of the software technologies group at Cambridge Consultants

High blood glucose levels associated with higher risk of wound-related complications

Discovery paves way for new therapeutic strategies to protect heart health of diabetes patients

Insulin interaction map could lead to new therapeutic targets for type 2 diabetes

Roadmap of protein interactions may lead to new therapeutic approaches for type 2 diabetes

Diabetes puts you at increased risk of flu-related complications

Study provides new insights into type 1 diabetes pathology

JDRF applauds FDA approval of Medtronic's MiniMed 530G with Enlite system for T1D

Dextrose gel could treat neonatal hypoglycemia

Research on bone-derived hormone could lead to new treatments for memory loss, depression

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News